Antonio Di Biagio
Antonio Di Biagio
Ospedale Policlinico San Martino Genova
Verified email at hsanmartino.it
TitleCited byYear
The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring
G Gatti, A Di Biagio, R Casazza, C De Pascalis, M Bassetti, M Cruciani, ...
Aids 13 (15), 2083-2089, 1999
1731999
Linezolid in the treatment of Gram-positive prosthetic joint infections
M Bassetti, F Vitale, G Melica, E Righi, A Di Biagio, L Molfetta, F Pipino, ...
Journal of Antimicrobial Chemotherapy 55 (3), 387-390, 2005
1262005
Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients
M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ...
The Journal of infectious diseases 211 (2), 178-186, 2014
1002014
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 …
A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ...
Journal of antimicrobial chemotherapy 70 (3), 930-940, 2014
842014
The effect of formulary restriction in the use of antibiotics in an Italian hospital
M Bassetti, A Di Biagio, B Rebesco, M Amalfitano, J Topal, D Bassetti
European journal of clinical pharmacology 57 (6-7), 529-534, 2001
612001
Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA)
M Bassetti, A Di Biagio, G Cenderello, V Del Bono, A Palermo, M Cruciani, ...
Journal of Infection 43 (2), 148-149, 2001
602001
Renal complications in HIV disease: between present and future
P Maggi, D Bartolozzi, P Bonfanti, L Calza, C Cherubini, A Di Biagio, ...
Permanyer Publications 14 (1), 37-53, 2012
552012
Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum β-lactamase-producing organisms in an intensive care unit
M Bassetti, E Righi, R Fasce, MP Molinari, R Rosso, A Di Biagio, ...
Journal of antimicrobial chemotherapy 60 (2), 433-435, 2007
542007
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation
F Marras, E Nicco, F Bozzano, A Di Biagio, C Dentone, E Pontali, S Boni, ...
Proceedings of the National Academy of Sciences 110 (29), 11970-11975, 2013
532013
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group
V Svicher, R D'Arrigo, C Alteri, M Andreoni, G Angarano, A Antinori, ...
New Microbiologica 33 (3), 195-206, 2010
512010
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study
GV De Socio, E Ricci, P Maggi, G Parruti, G Pucci, A Di Biagio, L Calza, ...
American journal of hypertension 27 (2), 222-228, 2013
482013
Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy
M Bassetti, A Di Biagio, B Rebesco, G Cenderello, ME Amalfitano, ...
International journal of antimicrobial agents 16 (3), 295-299, 2000
422000
Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine
R Maserati, A De Silvestri, A Uglietti, G Colao, A Di Biagio, B Bruzzone, ...
Aids 24 (7), 1013-1018, 2010
392010
Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies
VC Di Maio, V Cento, I Lenci, M Aragri, P Rossi, S Barbaliscia, M Melis, ...
Liver International 37 (4), 514-528, 2017
382017
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015
A Antinori, S Marcotullio, M Andreoni, A Chirianni, A d’Arminio Monforte, ...
New Microbiol 39 (2), 93-109, 2016
362016
Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy
R Rosso, M Vignolo, A Parodi, A Di Biagio, MP Sormani, M Bassetti, ...
AIDS Research & Human Retroviruses 21 (11), 927-932, 2005
362005
Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B
M Bassetti, F Bisio, A Di Biagio, I Pierri, M Balocco, O Soro, M Cruciani, ...
Journal of Antimicrobial Chemotherapy 54 (2), 575-577, 2004
362004
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study
MCF Prosperi, N Mackie, S Di Giambenedetto, M Zazzi, R Camacho, ...
Journal of antimicrobial chemotherapy 66 (8), 1886-1896, 2011
332011
Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals
M Bongiovanni, P Cicconi, S Landonio, P Meraviglia, L Testa, A Di Biagio, ...
International journal of antimicrobial agents 26 (1), 88-91, 2005
332005
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial
S Rusconi, P Vitiello, F Adorni, E Colella, E Focą, A Capetti, P Meraviglia, ...
PloS one 8 (11), e80157, 2013
322013
The system can't perform the operation now. Try again later.
Articles 1–20